1. Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients. (11th October 2015) Authors: Yutani, Shigeru; Ueshima, Kazuomi; Abe, Kazumichi; Ishiguro, Atsushi; Eguchi, Junichi; Matsueda, Satoko; Komatsu, Nobukazu; Shichijo, Shigeki; Yamada, Akira; Itoh, Kyogo; Sasada, Tetsuro; Kudo, Masatoshi; Noguchi, Masanori Other Names: Fridkis-Hareli Masha Academic Editor. Journal: Journal of immunology research Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗